Firm

Federal Judge Keeps Core Allegations Alive in Insulet Corp. Trade Secrets Case Against South Korean Firm

by

Boston, MA – In a recent legal development, a federal judge in Massachusetts has decided not to dismiss certain allegations in a lawsuit filed by Insulet Corp. against a South Korean manufacturer of insulin pump patches. The core of the dispute revolves around Insulet Corp.’s allegations that the defendant unlawfully appropriated trade secrets. The court also determined that the timing of when the plaintiff’s federal trade secrets claim was initiated should be decided by a jury. Insulet Corp., a prominent player in the medical device industry, primarily known for its innovative insulin delivery systems, accuses … Read more

Westminster Council Hires Law Firm to Probe Cause of Sagging Roads Amid Sewer Project Issues

by

Westminster, Colo. — In an effort to address persistent issues with sagging and settling roads in Westminster, the city council has enlisted a specialized law firm to investigate the underlying causes linked to recent infrastructure projects. The decision came after unanimous agreement during this week’s council meeting, where officials signed off on a $250,000 contract with Mill Construction Law LLC, a Denver-based firm known for its expertise in construction defects. The investigation will focus on scrutinizing the integrity of almost one and a half miles of sewer pipes laid beneath key thoroughfares, including North Huron … Read more

Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13

by

New York — Investors who purchased securities from Edwards Lifesciences Corporation between February 6, 2024, and July 24, 2024, are potentially eligible for compensation, as announced by Rosen Law Firm, a global investor rights legal practice. The firm, which focuses on securities class actions and shareholder derivative litigation, has set a lead plaintiff deadline of December 13, 2024. Anyone who acquired shares in Edwards Lifesciences during the said period might take part in the class action lawsuit without any out-of-pocket fees, as the costs are covered by a contingency fee arrangement. Those interested in joining … Read more

Rosen Law Firm Announces Key Deadline in GitLab Securities Class Action – Investors Urged to Act

by

New York – Investors who have acquired securities from GitLab Inc. are being reminded by the Rosen Law Firm, a global investor rights firm, of an upcoming November 4, 2024 deadline to apply as lead plaintiff in a major class-action lawsuit. This period concerns those who purchased GitLab’s securities between June 6, 2023, and March 4, 2024. Eligible investors might be entitled to compensation facilitated through a contingency fee arrangement requiring no direct out-of-pocket expenses. This lawsuit stems from accusations against GitLab Inc., claiming that executives made false and misleading statements about the company’s ability … Read more